REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$Â 65.04
0.00%
(0.00) Siku 1
14 Okt, 16:56:00 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya REGN34...
Fungua
R$Â 64.20
Juu
R$Â 65.04
Chini
R$Â 64.20
Mtaji wa soko
80.14B
Wastani wa kiasi cha mauzo
781.00
Kiasi cha mauzo ya hisa
136.00
Juu kwa wiki 52
R$Â 73.13
Chini kwa wiki 52
R$Â 49.91
Hisa za wawekezaji
101.14M
Idadi ya wafanyakazi
elfu 15
Fungua
R$Â 64.20
Juu
R$Â 65.04
Chini
R$Â 64.20
Mtaji wa soko
80.14B
Wastani wa kiasi cha mauzo
781.00
Kiasi cha mauzo ya hisa
136.00
Juu kwa wiki 52
R$Â 73.13
Chini kwa wiki 52
R$Â 49.91
Hisa za wawekezaji
101.14M
Idadi ya wafanyakazi
elfu 15
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Simply Wall Street
·
saa 1 iliyopita
Regeneron (REGN) Stock Looks Below Fair Value On Earnings
ad-hoc-news.de
·
saa 2 zilizopita
UBS upgrades Regeneron stock to Buy at USD 978.00 target
MarketBeat
·
saa 3 zilizopita
Perpetual Ltd Sells 1,598 Shares of Regeneron Pharmaceuticals, Inc. $REGN
Yahoo Finance
·
saa 13 zilizopita
What Could Send Regeneron Stock Higher?
Wasifu
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Kuhusu Regeneron Pharmaceuticals Inc BDR
Afisa Mkuu Mtendaji (CEO)Leonard Schleifer
Wafanyakazielfu 15.3
Lilianzishwa1988
Makao makuuTarrytown, New York, Marekani
Sekta-
Tovutiregeneron.com